We are live on ! Find out more
FNBT

FineMark National Bank & Trust Portfolio holdings

AUM $3.2B
1-Year Est. Return 18.28%
This Fund
S&P 500
This Quarter Est. Return
+6.67%
1 Year Est. Return
+18.28%
3 Year Est. Return
+69.81%
5 Year Est. Return
+87.67%
10 Year Est. Return
+274.39%
AUM
$837M
AUM Growth
+$95.9M
Cap. Flow
+$54.3M
Cap. Flow %
6.48%
Top 10 Hldgs %
23.93%
Holding
1,582
New
69
Increased
371
Reduced
363
Closed
244

Top Sells

Rank Stock Value
1
PSX icon
Phillips 66
PSX
+$3.96M
2
NVS icon
Novartis
NVS
+$2.92M
3
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$2.38M
4
BUD icon
AB InBev
BUD
+$2.25M
5
SNY icon
Sanofi
SNY
+$1.68M

Sector Composition

Rank Sector Weight
1 Healthcare 11.82%
2 Financials 11.38%
3 Industrials 11.03%
4 Technology 10.89%
5 Consumer Discretionary 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMA
401
DELISTED
Comerica
CMA
$127K 0.02%
3,021
FISV
402
Fiserv Inc
FISV
$27.4B
$127K 0.02%
2,790
-602
-18% -$28.3K
NATI
403
DELISTED
National Instruments Corp
NATI
$127K 0.02%
4,436
+180
+4% +$5.33K
VAR
404
DELISTED
Varian Medical Systems, Inc.
VAR
$127K 0.02%
1,798
-2,927
-62% -$202K
FAST icon
405
Fastenal
FAST
$59.8B
$126K 0.02%
12,372
+3,728
+43% +$36.7K
IGA
406
Voya Global Advantage and Premium Opportunity Fund
IGA
$158M
$126K 0.02%
11,700
+5,780
+98% +$62.7K
SCHM icon
407
Schwab US Mid-Cap ETF
SCHM
$15.2B
$125K 0.01%
9,339
+8,799
+1,629% +$119K
UHS icon
408
Universal Health Services
UHS
$9.84B
$124K 0.01%
1,041
+20
+2% +$2.44K
VVC
409
DELISTED
Vectren Corporation
VVC
$124K 0.01%
2,932
USG
410
DELISTED
Usg
USG
$123K 0.01%
5,077
BR icon
411
Broadridge
BR
$19B
$122K 0.01%
2,276
+104
+5% +$5.83K
GPN icon
412
Global Payments
GPN
$22.5B
$122K 0.01%
1,890
-192
-9% -$12.9K
CVG
413
DELISTED
Convergys
CVG
$122K 0.01%
4,900
SGBK
414
DELISTED
Stonegate Bank
SGBK
$121K 0.01%
3,683
ALV icon
415
Autoliv
ALV
$8.84B
$119K 0.01%
1,321
TDG icon
416
TransDigm Group
TDG
$68.7B
$119K 0.01%
523
FTR
417
DELISTED
Frontier Communications Corp.
FTR
$119K 0.01%
1,700
+6
+0.4% +$446
HBI
418
DELISTED
Hanesbrands
HBI
$118K 0.01%
4,014
+1,056
+36% +$31.7K
REGN icon
419
Regeneron Pharmaceuticals
REGN
$81.5B
$117K 0.01%
215
+2
+0.9% +$1.08K
RSP icon
420
Invesco S&P 500 Equal Weight ETF
RSP
$99.2B
$116K 0.01%
1,511
UGI icon
421
UGI
UGI
$7.62B
$116K 0.01%
3,450
ZTS icon
422
Zoetis
ZTS
$30.1B
$116K 0.01%
2,426
-155
-6% -$7K
PDP icon
423
Invesco Dorsey Wright Momentum ETF
PDP
$1.52B
$114K 0.01%
2,750
MXIM
424
DELISTED
Maxim Integrated Products
MXIM
$114K 0.01%
3,000
-144
-5% -$5.51K
COL
425
DELISTED
Rockwell Collins
COL
$113K 0.01%
1,226
-3,169
-72% -$281K

Similar funds

FineMark National Bank & Trust's Q4 2015 Portfolio in Review

As of Q4 2015, FineMark National Bank & Trust held 1,582 positions worth $837M, up 13% from $741M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

FineMark National Bank & Trust deployed $54.3M of net new capital in Q4 2015, opening 69 new positions and adding to 371 existing holdings. Its largest new stake was Alphabet (Google) Class C: 256,360 shares worth $9.73M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Phillips 66, an estimated $3.96M trimmed.

  • FineMark National Bank & Trust's largest Q4 2015 buy was Alphabet (Google) Class C: 256,360 shares worth $9.73M.
  • FineMark National Bank & Trust added most to iShares Russell 2000 ETF in Q4 2015, an estimated $6.76M increase.
  • FineMark National Bank & Trust's biggest Q4 2015 reduction was Phillips 66, cutting an estimated $3.96M.
  • FineMark National Bank & Trust fully exited Novartis in Q4 2015, selling an estimated $2.92M.
  • FineMark National Bank & Trust's ten largest holdings make up 24% of its $837M portfolio in Q4 2015.
  • FineMark National Bank & Trust opened 69 new positions and closed 244 in Q4 2015.
  • FineMark National Bank & Trust's portfolio value rose 13% quarter-over-quarter to $837M.

Based on FineMark National Bank & Trust's 13F filing for Q4 2015, filed 9 Feb 2016.